Product Description
Finerenone 20mg Tablets: What the Published Guidance Says
Human and analogue insulins alongside the oral hypoglycaemics and cardiorenal-metabolic agents added to the WHO Model List in its September 2025 revision.
Finerenone 20mg Tablets is specified against its own monograph, pack size and market registration, so the guidance below is worth reading together with the Diabetes & Insulin range overview.
- September 2025 added the GLP-1 class WHO added the GLP-1 receptor agonists semaglutide, dulaglutide and liraglutide, and the dual GLP-1/GIP agonist tirzepatide, for adults with type 2 diabetes where cardiovascular disease or chronic kidney disease is established and obesity is present (BMI ≥ 30 kg/m²). WHO — Essential medicines list updated to include key cancer and diabetes treatments (5 Sep 2025)
- The Model List details the insulin presentations and strengths Section 18.5.1 of the 24th WHO Model List (2025) lists human short-acting insulin as an injection solution of 40 IU/mL or 100 IU/mL in 10 mL vials and 100 IU/mL in 3 mL cartridges or pre-filled pens. Human intermediate-acting insulin is listed as an injection suspension in the same strengths, as compound insulin zinc suspension or isophane insulin. Long-acting and rapid-acting analogues are listed with glargine, degludec and detemir named among the therapeutic alternatives — a footnote notes that quality-assured biosimilars are included. WHO eEML — Medicines for diabetes
- The scale of the access problem WHO reports that more than 800 million people were living with diabetes in 2022, with half going untreated, and that more than one billion people worldwide are affected by obesity with rates rising fastest in low- and middle-income countries. WHO — Essential medicines list updated to include key cancer and diabetes treatments (5 Sep 2025)
We quote these sources rather than paraphrase them loosely, because the detail matters commercially for Finerenone 20mg Tablets. Where your national list differs from the WHO listing, the national list governs what may be supplied and promoted locally.
Supply & Specification Data for Finerenone 20mg Tablets
| Product Name | Finerenone Tablets (Finerenone 20mg Oral Tablets) |
| Specification | Each tablet contains: Finerenone 20mg |
| Dosage Form | Oral Film-Coated Tablet (for oral administration) |
| Active Ingredient | Finerenone |
| Pharmacological Class | Non-Steroidal Mineralocorticoid Receptor Antagonist (MRA) |
| Route of Administration | Oral administration (swallowed whole with water; take at approximately the same time each day, with or without food). |
| Storage | Store below 25°C, in a dry place, protected from light and moisture. Keep container tightly closed. Do not freeze. |
| Therapeutic group | Diabetes & Insulin — Diabetes & Insulin |
| Manufacturer | Sinophare Bio-technology Co., Ltd. (GMP, China) |
| Documentation supplied | COA, HPLC/GC data, stability data, dossier package |
The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Dapagliflozin 10mg Tablets, Canagliflozin 300mg Tablets, Empagliflozin 25mg Tablets, Ertugliflozin 15mg Tablets, Repaglinide Tablets 2mg, Sotagliflozin 400mg Tablets, Mixed Protamine Human Insulin 30R, Insulin Glargine Injection 100IU/mL 3ml Cartridge.
Testing, Monographs & Batch Documentation
Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.
Every batch of Finerenone 20mg Tablets is tested to the monograph stated on the purchase order. Where a monograph is silent on the presentation, we agree a written specification with you in advance and reference it on the certificate of analysis.
Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.
The batch record for this product normally includes:
- Testing for water content and pH where applicable
- Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)
- Testing for microbial limits and preservative efficacy (multi-dose presentations)
- Testing for heavy metals and elemental impurities
- Testing for packaging integrity and seal testing
- Testing for description and identification
COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.
Pack Configuration, Artwork & Shipping Documents
- Pack size: Blister pack (PVC-Alu) or HDPE bottle, typically 30 tablets per blister pack or bottle. Non-standard pack sizes can be quoted against your artwork.
- Storage: Store below 25°C, in a dry place, protected from light and moisture. Keep container tightly closed. Do not freeze..
- Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
- Labelling: we typeset the carton and leaflet in English, Arabic, French, Russian and Spanish and in any further language your market requires, carrying your own brand where the local rules allow.
- Export: commercial invoice, packing list, certificate of origin, GMP certificate, COA and the free-sale certificate issued by the country of manufacture whenever your customs or regulator asks for it.
Dossier, Authority Filings & Tender Documentation
Documents for Finerenone 20mg Tablets are issued by Sinophare Bio-technology Co., Ltd. — DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. Keeping one legal manufacturer across the COA, the GMP certificate and the registration file avoids assessment queries later.
- Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.
- Batch manufacturing and packaging records released for inspection on request during supplier audits.
- Re-test or renewal support when the marketing authorisation comes up for variation or renewal.
- CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
- Site Master File and GMP certificate for the manufacturing workshops.
The context for Finerenone 20mg Tablets is its place among medicines for diabetes listed in the WHO Model List. Listing status informs how programmes specify a product; it is not a substitute for the import licence or marketing authorisation of the destination country.
Buyer Questions about Finerenone 20mg Tablets
What pack size is available for Finerenone 20mg Tablets?
This presentation is normally supplied as Blister pack (PVC-Alu) or HDPE bottle, typically 30 tablets per blister pack or bottle. Where your market requires a different count, bottle or carton, we quote to your artwork and extend the stability file to the new pack.
What documentation comes with a shipment of Finerenone 20mg Tablets?
Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 36 months.
Does the batch documentation for Finerenone 20mg Tablets support a registration filing?
Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.
Which SGLT2 inhibitors do you supply?
Empagliflozin, dapagliflozin, canagliflozin and ertugliflozin in tablet form. Empagliflozin is the molecule specifically listed in section 18.5.2 of the Model List, with canagliflozin and dapagliflozin named as therapeutic equivalents.
How is insulin shipped?
Under temperature-controlled conditions with shipment temperature records. Confirm the exact cold-chain specification required for your market before ordering.
Other Diabetes & Insulin Products in This Range
- Dapagliflozin 10mg Tablets — 10mg
- Canagliflozin 300mg Tablets — 300mg
- Empagliflozin 25mg Tablets — 25mg
- Ertugliflozin 15mg Tablets — 15mg
- Repaglinide Tablets 2mg — 2mg
- Sotagliflozin 400mg Tablets — 400mg
Browse the full Diabetes & Insulin range; all Tablets; the complete product catalogue.
Request a Quotation for Finerenone 20mg Tablets
For tenders and programme supply, send the line item, pack size, quantity and destination for Finerenone 20mg Tablets 20mg. We return a quotation with lead time, documentation list and sample availability in one response.
Sources & Regulatory Notes
- WHO — Essential medicines list updated to include key cancer and diabetes treatments (5 Sep 2025)
- WHO eEML — Medicines for diabetes
Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.
